TARS·87650L103·US·equity·Healthcare - Biotechnology-13D/G
TARS (TARSUS PHARMACEUTICALS INC) is held by 138 institutional investors as of Q4 2025. Largest holders: BlackRock, Inc. ($310.4M), RTW INVESTMENTS, LP ($273.1M), VANGUARD GROUP INC ($196.5M). Net institutional sentiment: Mixed.
Showing 5 of 138 results.133 more with Pro.PROUpgrade to see all → |
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer